Download PDF
Thromb Haemost 1964; 11(01): 051-063
DOI: 10.1055/s-0038-1654805
Originalarbeiten — Original Articles — Travaux Originaux
Schattauer GmbH

Coagulation Studies in Liver Disease[*]

Acke Hallén
1   Coagulation Laboratory (Head: Associate Professor Inga Marie Nilsson) and the Medical Clinic (Head: Professor Jan Waldenstrom) University of Lund, Allmänna Sjukhuset, Malmö, Sweden
,
Inga Marie Nilsson
1   Coagulation Laboratory (Head: Associate Professor Inga Marie Nilsson) and the Medical Clinic (Head: Professor Jan Waldenstrom) University of Lund, Allmänna Sjukhuset, Malmö, Sweden
› Author Affiliations
Further Information

Publication History

Publication Date:
22 June 2018 (online)

Also available at
    Permissions and Reprints

Summary

Various caogulation factors were studied in 20 cases of liver cirrhosis for their possible diagnostic value. Special attention was given to determination of antithrombin (AT), and AT values were also studied in a series of hepatitis and obstructive jaundice.

The P & P test was decreased in 75%, the factor V content in 83%, the factor IX content in 40% and the platelet count in 55% of the cases of liver cirrhosis.

Increased fibrinolytic activity was noted in 5 cases. Only 2 cases had significantly decreased fibrinogen levels and most probably due to fibrinolysis. The AHF (f. VIII) level was slightly decreased in 2 cases, one of which had fibrinolysis, while the other had normal AHF levels.

In 12 of 18 cases of liver cirrhosis the AT II and III was decreased and only in one case was it increased but the decreased values deviated only slightly from the normal range. AT II and III in 23 cases of obstructive icterus and in 19 cases of hepatitis gave practically normal values.

Judging from our results determination of P & P and factor V is valuable in the diagnosis of liver cirrhosis. Determination of AT II and III by use of an improved method proved not to give any further help in the diagnosis of liver cirrhosis or the differential diagnosis between cirrhosis, hepatitis and obstructive jaundice.

* This investigation was supported by grants from the Swedish Medical Research Council.


 

  • References

  • 1 Alagille D, Hartmann L, Fauvert R. Etude analytique du temps de Quick au cours de l’insuffisance hépatique par les dosages différentiels de la prothrombin, de la proconvertine et de la proaccélérine. Sem. Hôp. Paris. 29: 3375 1953;
    PubMedSearch in Google Scholar
  • 2 Alagille D, Soulier J. P. Action des enzymes protéolytiques sur le sang total in vitro ; modifications des facteurs de coagulation et du complément. Sem. Hôp. Paris. 32: 355 1956;
    PubMedSearch in Google Scholar
  • 3 Alexander B, Goldstein R. Coagulation defect in hepatic disorders: deficiency of prothrom- bin-conversion accessory substances. J. clin. Invest. 29: 795 1950;
    PubMedSearch in Google Scholar
  • 4 Andersson L, Nilsson I. M, Olow B. Fibrinolytic activity in man during surgery. Thrombos. Diathes. haemorrh. (Stuttg.) 07: 391 1962;
    PubMedSearch in Google Scholar
  • 5 Beaumont J. L, Beaumont V, Domart A. Réchèrches sur l’activité fibrinolytique spontanée dn plasma dans les cirrhoses dn foie. Rev. franç. Etudes clin. biol. 01: 667 1956;
    PubMedSearch in Google Scholar
  • 6 Björkman S. E. A new method for enumeration of the platelets. Acta haemat. 22: 377 1959;
    CrossrefPubMedSearch in Google Scholar
  • 7 Blombäck B, Blombäck M. Purification of bovine and human fibrinogen. Arkiv for kemi. 10: 415 1956;
    PubMedSearch in Google Scholar
  • 8 Bradlow B. A, Antonis A, Bersohn I. Fibrinolytic activity in South African Bantu and white male subjects. S. Afr. med. J. Sci. 27: 15 1962;
    PubMedSearch in Google Scholar
  • 9 Broicher H, Egli H, Kesseler K, Oberhoffer G. Über die Bedeutung gerinnungsphysiologischer Untersuchungen bei akuten und chronischen Lebererkrankungen. Dtsch. Arch. klin. Med. 205: 292 1958;
    PubMedSearch in Google Scholar
  • 10 Broicher H, Egli H, Kesseler K. Clotting tests and liver function. Germ. med. Mth. 05: 161 1960;
    PubMedSearch in Google Scholar
  • 11 Cowling D. C. Coagulation defects in liver disease. J. clin. Path. 09: 347 1956;
    CrossrefPubMedSearch in Google Scholar
  • 12 Dausset J, Paraf A, Bergerot-Blondel Y, Garoli J. La fibrinolyse latente des cirrhoses du foie. Ann. Rech. méd. 32: 1033 1956;
    PubMedSearch in Google Scholar
  • 13 Egeberg O. Antihemophilic A factor (tactor VIII) and fibrinogen in human blood. Scand. J. clin. Lab. Invest. 14: 230 1962;
    CrossrefPubMedSearch in Google Scholar
  • 14 Fearnley R. Plasma fibrinolytic activity in cirrhosis of the liver. Lancet. I: 450 1956;
    PubMedSearch in Google Scholar
  • 15 Fell G, Ivanovic N, Johnsson A. S, Seegers W. H. Differentiation of plasma antithrombin activities. Proc. Soc. exp. Biol. 85: 199 1954;
    CrossrefPubMedSearch in Google Scholar
  • 16 Finkbiner K. B, McGovern J. J, Goldstein R, Bunker J. P. Coagulation defects in liver disease and response to transfusion during surgery. Amer. J. Med. 26: 199 1959;
    CrossrefPubMedSearch in Google Scholar
  • 17 Griffith W. H. Plasma antithrombin in thrombosis, haemorrhage and liver disease. L. Jab. clin. Med. 40: 367 1952;
    PubMedSearch in Google Scholar
  • 18 Hallen A. A method for measuring antithrombin. Thrombos. Diathes. haemorrh. (Stuttg.) 08: 56 1962;
    PubMedSearch in Google Scholar
  • 19 Harrington W. J, Desforges F. J, Minkel H. P, Crow C. B, Stohlman F. The bleeding tendency in hepatocellular and obstructive jaundice. Bull. New Engl. med. Cent. 12: 121 1950;
    PubMedSearch in Google Scholar
  • 20 Hedenberg L, Korsan-Bengtsen K. Clotting tests and other tests of the hemostatic mechanism in cirrhosis of the liver and their diagnostic significance. Acta med. scand. 172: 229 1962;
    PubMedSearch in Google Scholar
  • 21 Imdahl H, Egli H, Kesseler K, Hennrick G. Über den Wert gerinnungsphys. Untersuchungen bei Erkrankungen der Leber und des Gallengangsystems in der Chirurgie. Arztl. Wschr. 12: 481 1957;
    PubMedSearch in Google Scholar
  • 22 Innerfield I, Angrist A, Boyd L. J. Plasma antithrombin titer in incipient and advanced liver failure. Gastroenterology. 20: 417 1952;
    PubMedSearch in Google Scholar
  • 23 Jürgens J. Neue Bestimmungsmethoden und Bedeutung der Antithrombine für die Klinik. Klin. Wschr. 35: 303 1957;
    CrossrefPubMedSearch in Google Scholar
  • 24 Jürgens R, Trautwein H. Über Fibrinopenie (Fibrinogenopenie) beim Erwachsenen nebst Bemerkungen über die Herkunft des Fibrinogens. Dtsch. Arch. klin. Med. 169: 28 1930;
    PubMedSearch in Google Scholar
  • 25 Koller F, Fritschy W. Über die Bedeutung des Antithrombins. Acta med. Helv. 14: 263 1947;
    PubMedSearch in Google Scholar
  • 26 Kwaan H. C, McFadzean AJS, Cook J. Plasma fibrinolytic activity in cirrhosis of the liver. Lancet. I: 133 1956;
    PubMedSearch in Google Scholar
  • 27 Loeliger A, Hers JFPh. Chronic antithrombinaemia (antithrombin V) with haemorrhagic diathesis in a case of rheumatoid arthritis with hypergammaglobulinaemia. Thrombos. Diathes. haemorrh. (Stuttg.) 01: 499 1957;
    PubMedSearch in Google Scholar
  • 28 Miller L. L, Bale W. F. Synthesis of all plasma protein fractions except gamma globulins by the liver. J. Exper. Med. 99: 125 1954;
    CrossrefPubMedSearch in Google Scholar
  • 29 Neumayr A, Parzer O. Die klinische Bedeutung der Antithrombinteste. Dtsch. med. Wschr. 81: 161 1956;
    Thieme ConnectPubMedSearch in Google Scholar
  • 30 de Nicola P, Soardi F. Fibrinolysis in liver diseases. Study of 109 cases by means of the fibrin plate method. Thrombos. Diathes. haemorrh. (Stuttg.) 02: 290 1958;
    PubMedSearch in Google Scholar
  • 31 Niewiarowski S, Kowalski E. Formation of an antithrombinlike anticoagulant during proteolysis of fibrinogen. Bull. Acad. pol. Sci. 05: 169 1957;
    PubMedSearch in Google Scholar
  • 32 Niléhn J-E. On symptomatic antihaemophilic globulin (AHF) deficiency. Acta med. scand. 171: 491 1962;
    PubMedSearch in Google Scholar
  • 33 Nilsson I. M, Björkman S. E, Andersson L. Clinical experiences with e-aminocaprioc acid (e-ACA) as an antifibrinolytic agent. Acta med. scand. 170: 487 1961;
    PubMedSearch in Google Scholar
  • 34 Nilsson I. M, Blombäck M, Francken I. v. On an inherited autosomal hemorrhagic diathesis with antihaemophilic globulin (AHG) deficiency and prolonged bleeding time. Acta med. scand. 159: 35 1957;
    PubMedSearch in Google Scholar
  • 35 Nilsson I. M, Blombäck M, Ramgren O. Haemophilia in Sweden. I. Coagulation studies. Acta med. scand. 170: 665 1961;
    PubMedSearch in Google Scholar
  • 36 Nilsson I. M, Nosslin B, Serin F. Personal communications..
    PubMed
  • 37 Nilsson I. M, Olow B. Determination of fibrinogen and fibrinogenolytic activity. Thrombos. Diathes. haemorrh. (Stuttg.) 08: 297 1962;
    PubMedSearch in Google Scholar
  • 38 Nilsson I. M, Olow B. Fibrinolysis induced by streptokinase in man. Acta chir. scand. 123: 247 1962;
    PubMedSearch in Google Scholar
  • 39 Nilsson I. M, Sjoerdsma A, Waldenstrom J. Antifibrinolytic activity and metabolism of s-aminocaproic acid in man. Lancet. I: 1322 1960;
    PubMedSearch in Google Scholar
  • 40 Owren P. A. The diagnostic and prognostic significance of plasma prothrombin and factor V levels in parenchymatous hepatitis and obstructive jaundice. Scand. J. clin. Lab. Invest. 01: 131 1949;
    CrossrefPubMedSearch in Google Scholar
  • 41 Rapaport S. I, Ames S. B, Mikkelsen S, Goodman J. R. Plasma clotting factors in chronic hepatocellular disease. New Engl. J. Med. 263: 278 1960;
    CrossrefPubMedSearch in Google Scholar
  • 42 Ratnoff O. D. Studies on proteolytic enzyme in human plasma. IV. The rate of lysis of plasma clots in normal and diseased individuals, with particular reference to hepatic disease Bull. Johns Hopkins Hosp. 84: 29 1949;
    PubMedSearch in Google Scholar
  • 43 Risak E. Die Fibrinopenie. Z. klin. Med. 128: 605 1935;
    PubMedSearch in Google Scholar
  • 44 Sokal G, Schmidt F, Hörder M. H. Die Antithrombinaktivitäten des Plasmas bei Lebererkrankungen und Verschlußikterus. Klin. Wschr. 33: 934 1955;
    CrossrefPubMedSearch in Google Scholar
  • 45 Stefanini M. The hemorrhagic diathesis of liver dysfunction and obstruction jaundice. Proc. 3 internat, congress soc. of haemat. Cambridge; 1950: 484.
    Search in Google Scholar
  • 46 Weaver W. T, Anlyan W. G, Postlethweit R. W. Blood coagulation factors in liver disease. Surgery. 50: 207 1961;
    PubMedSearch in Google Scholar
  • 47 Witte S, Dirnberger P. Klinische Untersuchungen über die Gerinnungsfaktoren Prothrombin, Faktor V und Faktor VII bei Lebererkrankungen und ihre Beeinflussung durch Vitamin K, und Synka-Vit. Klin. Wschr. 31: 781 1953;
    CrossrefPubMedSearch in Google Scholar
  • 48 Witte S, Dirnberger P. Plasma-antithrombin und Thrombininhibitor bei Leberparenchym - und Gallenwegskrankheiten. Klin. Wschr. 33: 705 1955;
    CrossrefPubMedSearch in Google Scholar
  • 49 Volkert M. Studies on the antithrombin content of the blood and it’s relation to heparin. Acta physiol, scand. suppl. 15 1942
    PubMedSearch in Google Scholar
  • 50 Zetterqvist E, Francken I. v. Koagulationsfaktorerna vid leversjukdom. Nord. Med. 69: 81 1963;
    PubMedSearch in Google Scholar